Continued Benefit From Paclitaxel-Eluting Compared With Bare-Metal Stent Implantation in Saphenous Vein Graft Lesions During Long-Term Follow-Up of the SOS (Stenting of Saphenous Vein Grafts) Trial
- 1 February 2011
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 4 (2) , 176-182
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Gilead Sciences
- St. Jude Medical
This publication has 34 references indexed in Scilit:
- Comparison of Drug-Eluting and Bare Metal Stents for Saphenous Vein Graft Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)The American Journal of Cardiology, 2010
- Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-AnalysisPLOS ONE, 2010
- Comparison of the Long-Term Safety and Efficacy of Drug-Eluting and Bare-Metal Stent Implantation in Saphenous Vein GraftsCirculation: Cardiovascular Interventions, 2010
- Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft InterventionThe American Journal of Cardiology, 2010
- Effectiveness and safety of drug-eluting stents in vein grafts: A meta-analysisAmerican Heart Journal, 2010
- Drug-eluting versus bare-metal stents for treating saphenous vein graftsAmerican Heart Journal, 2009
- Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel InterventionsCardiology, 2008
- Long‐term clinical outcomes of real‐world experience using sirolimus‐eluting stents in saphenous vein graft diseaseCatheterization and Cardiovascular Interventions, 2008
- Late outcomes of drug‐eluting versus bare metal stents in saphenous vein grafts: Propensity score analysisCatheterization and Cardiovascular Interventions, 2008
- Efficacy of Sirolimus‐Eluting Stents as Compared to Paclitaxel‐Eluting Stents for Saphenous Vein Graft InterventionJournal of Interventional Cardiology, 2006